RecruitingNot ApplicableNCT07193485

Efficacy of Buteyko Breathing in Seniors With Chronic Eustachian Tube Dysfunction


Sponsor

Cairo University

Enrollment

40 participants

Start Date

May 12, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

Eustachian tube dysfunction is distressing probelm. drugs usually are not effective. compelemtary tehrapies like Buteyko breathing may be effective


Eligibility

Min Age: 65 YearsMax Age: 75 Years

Inclusion Criteria4

  • Eustachian Tube Dysfunction (chronic obstructive form)
  • unilateral ear affetion
  • senior patients
  • chronci affection more than 3 months

Exclusion Criteria2

  • obesity
  • cardiac probelms repsiratory problems

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERButeyko breathing

twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group I and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks. Also, group I will aslo receive 30-min Buteyko breathing two times daily for 14 weeks.

OTHERusual care

twenty seniors with Eustachian tube dysfunction (chronic obstructive form) will be ranomized to group II and this group will take usual care (budesonide spray in nose in 64 microgram concentration one time per day plus the intake of a tablet two times daily containing containing 20-mg contration of pseudoephedrine hydrochloride and 5-mg concentration of loratadine) for 2 weeks.


Locations(1)

Cairo University

Dokki, Giza Governorate, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07193485


Related Trials